Masanori Nakasu

Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy.

T. Yamashita, I. Ono, Hai-ying Jin, 2004, Biomaterials.

Tissue response to a newly developed calcium phosphate cement containing succinic acid and carboxymethyl-chitin.

T. Kohgo, A. Yokoyama, Masanori Nakasu, 2003, Journal of biomedical materials research. Part A.

Long-term antibacterial activity of vancomycin from calcium phosphate cement in vivo.

K. Urabe, Masanori Nakasu, M. Mukai, 2021, Bio-medical materials and engineering.

Antibiotic elution profile and physical properties of a novel calcium phosphate cement material

Masanori Nakasu, K. Sugo, T. Nakajima, 2016 .

Development of calcium phosphate cement using chitosan and citric acid for bone substitute materials.

Atsuro Yokoyama, Takao Kohgo, Takao Kawasaki, 2002, Biomaterials.

Development of superporous hydroxyapatites and their examination with a culture of primary rat osteoblasts.

Masanori Nakasu, M. Sakamoto, T. Matsumoto, 2007, Journal of biomedical materials research. Part A.

Comparison of in vivo bioactivity and compressive strength of a novel superporous hydroxyapatite with beta-tricalcium phosphates

Masanori Nakasu, Y. Okanoue, T. Tani, 2012, Archives of Orthopaedic and Trauma Surgery.

Development of Calcium Phosphate Cement Containing Carboxymethyl-Chitin and Succinic Acid for Bone Substitute.

T. Kohgo, A. Yokoyama, Masanori Nakasu, 2000 .